P WUXI PHARMATECH AN INTEGRATED R&D SERVICE COMPANY - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
77188954
Word Mark
P WUXI PHARMATECH AN INTEGRATED R&D SERVICE COMPANY
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2011-07-18
Filing Date
2007-05-23
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261713, 280103 - Letters or words underlined and/or overlined by one or more strokes or lines. Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters.
Published for Opposition Date
2008-03-25
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
SOBRAL, CHRISTINA
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"WUXI PHARMATECH AN INTEGRATED R&D SERVICE COMPANY" AND THE NON-LATIN CHARACTERS THAT MEAN "MEDICINE" AND "HEALTH"
Description of Mark
The mark consists of a stylized P, Chinese characters and a slogan .
Goods and Services
Pharmaceutical research and development; Scientific research and development; Consultation in the field of pharmaceutical research and development; Product research and development; Chemical laboratories; Chemical research; Chemical analysis; pharmaceutical research services, namely mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for drug metabolite profiling, drug metabolite identification, and drug metabolite quantitation; pharmaceutical product evaluation, namely mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for drug metabolite profiling, drug metabolite identification, and drug metabolite quantitation; pharmaceutical research services, namely, Mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for biomarker profiling; pharmaceutical product evaluation, namely, mass spectrometry-based pharmacokinetics and pharmacodynamics (PK/PD) for biomarker profiling; Executing of chemical analyses; Scientific research, namely conducting clinical trials; Testing of pharmaceuticals
Pseudo Mark
PHARMACEUTICAL WUXI PHARMACEUTICAL TECH AN INTEGRATED R AND D SERVICE COMPANY
Transliteration Statement
The non-Latin character(s) in the mark transliterate into YAO MING KANG DE, and this means MEDICINE BRIGHT HEALTH MORAL in English.
Classification Information
International Class
42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2007-05-30
Primary Code
042
Correspondences
Name
Mark E. Miller
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2007-05-30 | NEW APPLICATION ENTERED IN TRAM |
2007-05-31 | NOTICE OF DESIGN SEARCH CODE AND PSEUDO MARK MAILED |
2007-09-04 | ASSIGNED TO EXAMINER |
2007-09-05 | NON-FINAL ACTION WRITTEN |
2007-09-05 | NON-FINAL ACTION E-MAILED |
2007-09-05 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2007-09-05 | NON-FINAL ACTION WRITTEN |
2007-09-05 | NON-FINAL ACTION E-MAILED |
2007-09-05 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2008-01-15 | EXAMINERS AMENDMENT -WRITTEN |
2008-01-15 | EXAMINERS AMENDMENT E-MAILED |
2008-01-15 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2008-01-15 | EXAMINER'S AMENDMENT ENTERED |
2008-01-16 | EXAMINERS AMENDMENT -WRITTEN |
2008-01-16 | EXAMINERS AMENDMENT E-MAILED |
2008-01-16 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2008-01-16 | EXAMINER'S AMENDMENT ENTERED |
2008-01-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2008-02-19 | ASSIGNED TO LIE |
2008-02-19 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2008-03-05 | NOTICE OF PUBLICATION |
2008-03-25 | PUBLISHED FOR OPPOSITION |
2008-06-17 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2008-09-04 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-12-11 | TEAS EXTENSION RECEIVED |
2008-12-17 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2008-12-29 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2008-12-11 | EXTENSION 1 FILED |
2008-12-29 | EXTENSION 1 GRANTED |
2009-05-08 | TEAS EXTENSION RECEIVED |
2009-05-08 | EXTENSION 2 FILED |
2009-05-08 | EXTENSION 2 GRANTED |
2009-12-16 | TEAS EXTENSION RECEIVED |
2009-12-16 | EXTENSION 3 FILED |
2009-12-16 | EXTENSION 3 GRANTED |
2010-06-14 | TEAS EXTENSION RECEIVED |
2010-06-14 | EXTENSION 4 FILED |
2010-06-14 | EXTENSION 4 GRANTED |
2010-06-16 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2010-12-10 | TEAS EXTENSION RECEIVED |
2010-12-10 | EXTENSION 5 FILED |
2010-12-10 | EXTENSION 5 GRANTED |
2010-12-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2011-07-18 | ABANDONMENT - NO USE STATEMENT FILED |
2011-07-18 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |